With a market cap of $154.3 billion, Boston Scientific Corporation (BSX) is a global developer, manufacturer, and marketer of ...

This was the stock's second consecutive day of losses.

If you are looking for a stock that has a solid history of beating earnings estimates and is in a good position to maintain ...

Benfica coach Filipa Patão has been hired as the new head coach of the National Women’s Soccer League club Boston Legacy. Patão will take over the expansion team’s preparations for its ...

Aliyah Boston scored a career-high 31 points and Kelsey Mitchell chipped in 26 points and five 3-pointers as the Indiana ...

Outlook: Boston Scientific forecasts net sales growth of approximately 15%-17% in 2025 on a reported basis and around 12%-14% on an organic basis, compared to prior guidance of 12.5%-14.5% and 10% ...

For the full year, Boston Scientific sees adjusted EPS of $2.87 to $2.94 and sales up 15% to 17%, above Visible Alpha projections.

Boston Scientific plans to break ground soon on a major expansion in Maple Grove, a project that’s up for $1.66 million in awards from DEED's Job Creation Fund.

Boston Scientific's (NYSE:BSX) stock is up by a considerable 11% over the past three months. However, we wonder if the company's inconsistent financials would have any adverse impact on the ...

This week, Mustang Bio left its Worcester facility for a new home base, Novo Nordisk partnered with an MIT-founded biotech and Eli Lilly and Co. struck a deal with a Boston biotech to work on ...

Boston Scientific Q4 revenue rose 22.4% Y/Y to $4.56B, exceeding the $4.424B consensus. Adjusted EPS of $0.70 beat expectations of $0.66. Cardiovascular sales grew 28.8% to $2.94B, with cardiology ...

Boston Scientific (BSX) closed the most recent trading day at $101.64, moving +1.33% from the previous trading session. The stock exceeded the S&P 500, which registered a gain of 0.53% for the day ...